Skip to content
Longterm Wiki

New Expert Appointments to CEPI's Board and Scientific Advisory Committee (May 2022)

web

Credibility Rating

4/5
High(4)

High quality. Established institution or organization with editorial oversight and accountability.

Rating inherited from publication venue: CEPI

This press release announces leadership changes at CEPI (Coalition for Epidemic Preparedness Innovations), a global health organization focused on pandemic preparedness. While not directly about AI safety, CEPI's governance model and international coordination mechanisms offer analogies relevant to global biosecurity and pandemic risk governance discussions.

Metadata

Importance: 8/100press releasenews

Summary

CEPI announced new appointments to its Board and Scientific Advisory Committee in May 2022, including five new Board members and a new SAC Chair. Dr. Richard Hatchett was re-appointed as CEO for a second five-year term, and Yasuhisa Shiozaki was named CEPI's first Global Goodwill Ambassador.

Key Points

  • Five new public health leaders joined the CEPI Board, including representatives from Indonesia, Africa, and the Bill & Melinda Gates Foundation.
  • Dr. Emmanuel Hanon (former GSK Vaccines R&D Head) confirmed as next Chair of CEPI's Scientific Advisory Committee.
  • Yasuhisa Shiozaki appointed as CEPI's first Global Goodwill Ambassador to raise international awareness of CEPI's mission.
  • Dr. Richard Hatchett re-appointed as CEPI CEO for a second five-year term.
  • Several long-serving Board members stepped down, including Professor Baron Peter Piot and Sir Jeremy Farrar.

Cached Content Preview

HTTP 200Fetched May 18, 202619 KB
Facebook LinkedIn X ■ Five public health and scientific leaders join CEPI Board: Dr L. Rizka Andalucia, Mr. Cyrus Ardalan, Dr Githinji Gitahi, Professor Samba Sow, and Dr. Anita Zaidi 

 ■ Former Head of GSK Vaccine R&D, Dr Emmanuel Hanon, confirmed as next Chair of CEPI Scientific Advisory Committee, and Dr Laura Palomares joins Mr. Michael King as vice-chairs 

 ■ Yasuhisa Shiozaki appointed as CEPI's first Global Goodwill Ambassador 

 ■ Dr Richard Hatchett re-appointed as CEPI CEO for a second five-year term 

 06 May 2022, Oslo, Norway — The Coalition for Epidemic Preparedness Innovations today announced changes and additions to its Board and Scientific Advisory Committee, both of which provide critical oversight of and advice to CEPI.

The new appointments to the CEPI Board are:

 ■ Dr L. Rizka Andalucia , Director-General for Pharmaceutical and Medical Devices at the Ministry of Health of the Republic of Indonesia, as Board voting member (investor)

 ■ Cyrus Ardalan, Chairman of OakNorth Bank, Trustee of the Charities Aid Foundation (CAF), and a senior adviser at Alvarez and Marsal, as Board voting member (independent)

 ■ Dr Githinji Gitahi , Group Chief Executive Officer, Amref Health Africa, as Board voting member (independent)

 ■ Professor Samba Sow , Director General of the Center for Vaccine Development — Mali (CVD-Mali) and former Minister of Health for Mali, as Board voting member (independent)

 ■ Anita Zaidi, Director of the Vaccine Development, Surveillance, and Enteric and Diarrheal Diseases programs and President, Gender Equality Division, Bill & Melinda Gates Foundation (investor)

The new appointments to CEPI's Scientific Advisory Committee are:

 ■ Dr Emmanuel Hanon, Former Head of Vaccines Research & Development, GSK, and current Head of R&D for Viome, as Chair

 ■ Dr Laura Palomares, Principal Researcher and Professor, Instituto de Biotecnología, Universidad Nacional Autónoma de México (UNAM), will join Mr. Michael King as an additional Vice Chair

In addition, CEPI is also pleased to announce the appointment of Mr. Yasuhisa Shiozaki (former Member of the House of Representatives, Japan; former Chief Cabinet Secretary in the Government of Japan; and a member of the Global Leaders Group on Antimicrobial Resistance) as CEPI's first Global Goodwill Ambassador, in recognition of his outstanding commitment to CEPI's mission and contributions to CEPI's establishment and growth over many years. In this newly created role, Mr. Shiozaki will represent CEPI internationally in a variety of forums, raising awareness of CEPI's mission, aspirations, and accomplishments.

Dr Richard Hatchett has also been re-appointed to serve as CEPI CEO for a second five-year term.

The changes to the Board and Scientific Advisory Committee come as existing Board members Professor Baron Peter Piot (former Director of the London School of Hygiene and Tropical Medicine and a Handa Professor of Global Health), Dr John Nkengasong (Director of Africa Cent

... (truncated, 19 KB total)
Resource ID: bca2c6c8e517e142 | Stable ID: sid_OhoEq9437g